InvestorsHub Logo
Followers 2
Posts 922
Boards Moderated 0
Alias Born 06/02/2012

Re: None

Friday, 05/03/2024 12:08:40 PM

Friday, May 03, 2024 12:08:40 PM

Post# of 14912
Good report out on CG0070 at today's AUA Annual Meeting.

May 3 Results

It also looks like one of the original Ceregene founders is still looking at using our AAV2 technology to treat Alzheimers, this time with a different payload. Here's the phase 1 clinical trial that is underway. Even if this works, by the time it completes its testing and regulatory approval, I can't imagine we would have any stake remaining.

AAV2-BDNF Clinical Trial
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ANIP News